hsTropI: an early biomarker of acute coronary syndrome & MI

  • Dr Sohini Sengupta Neogi Department of Biochemistry, BLK Superspeciality Hospital, Pusa Road, Rajinder, Nagar, New Delhi, India
  • Dr Raj Kumar Kapoor Department of Biochemistry, BLK Superspeciality Hospital, Pusa Road, Rajinder, Nagar, New Delhi, India
Keywords: Hs TroponinI (hsTropI), Acute coronary syndrome, Non ST elevation MI

Abstract

In the Emergency Department cardiac troponins are the preferred biomarkers for the diagnosis of acute myocardial infarction (MI) and are useful for risk stratification of patients with acute coronary syndrome (ACS) and stable ischemic heart disease. The introduction of ‘high sensitivity’ Troponins (hscTn) in many tertiary care centers has transformed the diagnostic scenario, wherein, the time from onset of chest pain to its diagnosis has significantly been reduced. With the advent of new hsTnI assays, which have a low limit of detection, low imprecision and low reference limits, the possibility of more patients with unstable angina being classified as having non-ST-elevation myocardial infarction (NSTEMI) will now increase. Its use will identify more high-risk patients with undifferentiated chest pain, that will help ‘rule-in’ or ‘rule-out’ acute myocardial infarction. In conclusion, it may be said that hsTropI is a sensitive, albeit less specific marker of MI. In patients of mildly elevated hsTropI and without evidence of ST elevation, a serial assessment of the biomarker is suggested. This will likely translate into more improved outcomes in this difficult patient population when ECG findings and clinical presentation do not suggest a clear diagnosis.

Downloads

Download data is not yet available.

References

Thygesen K, Alpert JS, White HD; Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Eur Heart J. 2007 Oct;28(20):2525-38.

Morrow DA, Cannon CP, Jesse RL, Newby LK, Ravkilde J, Storrow AB, et al. National Academy of Clinical Biochemistry. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Circulation. 2007 Apr 3;115(13):e356-75. Epub 2007 Mar 23.

Gaze DC, Collinson PO. Multiple molecular forms of circulating cardiac troponin: analytical and clinical significance. Ann Clin Biochem. 2008 Jul;45(Pt 4):349-55. doi: https://doi.org/10.1258%2Facb.2007.007229.

Apple FS. A new season for cardiac troponin assays: it's time to keep a scorecard. Clin Chem. 2009 Jul;55(7):1303-6. doi: https://doi.org/10.1373/clinchem.2009.128363. Epub 2009 May 28.

Jesse RL. On the relative value of an assay versus that of a test: a history of troponin for the diagnosis of myocardial infarction. J Am Coll Cardiol. 2010 May 11;55(19):2125-8. doi: https://doi.org/10.1016/j.jacc.2010.03.014.

Reichlin T, Hochholzer W, Bassetti S, Steuer S, Stelzig C, Hartwiger S, et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med. 2009 Aug 27;361(9):858-67. doi: https://doi.org/10.1056/NEJMoa0900428.

Thygesen K, Mair J, Giannitsis E, Mueller C, Lindahl B, Blankenberg S, et al; Study Group on Biomarkers in Cardiology of ESC Working Group on Acute Cardiac Care. How to use high-sensitivity cardiac troponins in acute cardiac care. Eur Heart J. 2012 Sep;33(18):2252-7. Epub 2012 Jun 21.

Wijnker PJ, Li Y, Zhang P, Foster DB, dos Remedios C, Van Eyk JE et al. A novel phosphorylation site, Serine 199, in the C-terminus of cardiac troponin I regulates calcium sensitivity and susceptibility to calpain-induced proteolysis.J Mol Cell Cardiol. 2015 May;82:93-103. doi: https://doi.org/10.1016/j.yjmcc.2015.03.006. Epub 2015 Mar 11.

Lyngbakken MN, Røsjø H, Holmen OL, Nygård S, Dalen H, Hveem K et al. High-Sensitivity Troponin I, and the Risk of Cardiovascular Events (from the Nord-Trøndelag Health Study).Am J Cardiol. 2016 Sep 15;118(6):816-21. doi: https://doi.org/10.1016/j.amjcard.2016.06.043. Epub 2016 Jun 28.

Trambas C, Pickering JW, Than M, Bain C, Nie L, Paul E et al. Impact of High-Sensitivity Troponin I Testing with Sex-Specific Cutoffs on the Diagnosis of Acute Myocardial Infarction.Clin Chem. 2016 Jun;62(6):831-8. doi: https://doi.org/10.1373/clinchem.2015.252569. Epub 2016 Apr 26.

Bossard M, Thériault S, Aeschbacher S, Schoen T, Kunz S, von Rotz M et al. Factors independently associated with cardiac troponin I levels in young and healthy adults from the general population.Clin Res Cardiol. 2016 Aug 17. (Epub ahead of print)

Sandoval Y, Smith SW, Shah AS, Anand A, Chapman AR, Love SA et al. Rapid Rule-Out of Acute Myocardial Injury Using a Single High-Sensitivity Cardiac Troponin IMeasurement.Clin Chem. 2016 Nov 3. pii: clinchem.2016.264523. (Epub ahead of print)

Love SA, Sandoval Y, Smith SW, Nicholson J, Cao J, Ler R, et al. Incidence of Undetectable, Measurable, and Increased Cardiac Troponin I Concentrations Above the 99th Percentile Using a High-Sensitivity vs a Contemporary Assay in Patients Presenting to the Emergency Department. Clin Chem. 2016 Aug;62(8):1115-9. doi: https://doi.org/10.1373/clinchem.2016.256305. Epub 2016 Jun 20.

Westwood M, van Asselt T, Ramaekers B, Whiting P, Thokala P, Joore M et al. High-sensitivity troponin assays for the early rule-out or diagnosis of acute myocardial infarction in people with acute chest pain: a systematic review and cost-effectiveness analysis.Health Technol Assess. 2015 Jun;19(44):1-234. doi: 10.3310/hta19440.15. Clin Chem. 2016 Mar;62(3):494-504. doi: 10.1373/clinchem.2015.249508. Epub 2016 Jan 21.

Reichlin T, Cullen L, Parsonage WA, Greenslade J, Twerenbold R, Moehring B, et al. Two-hour algorithm for triage toward rule-out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin T. Am J Med. 2015 Apr;128(4):369-79.e4. doi: https://doi.org/10.1016/j.amjmed.2014.10.032. Epub 2014 Nov 13.

Pickering JW, Young JM, George P, Aldous S, Cullen L, Greenslade JH et al. The utility of presentation and 4-hour high sensitivity troponin I to rule-out acute myocardial infarction in the emergency department.Clin Biochem. 2015 Dec;48(18):1219-24. doi: https://doi.org/10.1016/j.clinbiochem.2015.07.033. Epub 2015 Jul 29.

Rubini Gimenez M, Twerenbold R, Jaeger C, Schindler C, Puelacher C, Wildi K, et al. Campodarve I, Rentsch K, Bassetti S, Osswald S, Mueller C. One-hour rule-in and rule-out of acute myocardial infarction using high-sensitivity cardiac troponin I. Am J Med. 2015 Aug;128(8):861-870.e4. doi: https://doi.org/10.1016/j.amjmed.2015.01.046. Epub 2015 Mar 31.

Cullen L, Greenslade JH, Carlton EW, Than M, Pickering JW, Ho A et al. Sex-specific versus overall cut points for a high sensitivity troponin I assay in predicting 1-year outcomes in emergency patients presenting with chest pain.Heart. 2016 Jan;102(2):120-6. doi: http://dx.doi.org/10.1136/heartjnl-2015-308506.

Jaeger C, Wildi K, Twerenbold R, Reichlin T, Rubini Gimenez M, Neuhaus JD, et al. One-hour rule-in and rule-out of acute myocardial infarction using high-sensitivity cardiac troponin I. Am Heart J. 2016 Jan;171(1):92-102.e1-5. doi: https://doi.org/10.1016/j.ahj.2015.07.022. Epub 2015 Jul 26.

Eggers KM, Aldous S, Greenslade JH, Johnston N, Lindahl B, Parsonage WA et al. Two-hour diagnostic algorithms for early assessment of patients with acute chest pain--Implications of lowering the cardiac troponin I cut-off to the 97.5th percentile.Clin Chim Acta. 2015 May 20;445:19-24. doi: https://doi.org/10.1016/j.cca.2015.03.002. Epub 2015 Mar 11.

Hoeller R, Rubini Giménez M, Reichlin T, Twerenbold R, Zellweger C, Moehring B et al. Normal presenting levels of high-sensitivity troponin and myocardial infarction.Heart. 2013 Nov;99(21):1567-72. doi: http://dx.doi.org/10.1136/heartjnl-2013-303643. Epub 2013 Apr 19.

Schreiber DH, Agbo C, Wu AH. Short-term (90 min) diagnostic performance for acute non-ST segment elevation myocardial infarction and 30-day prognostic evaluation of a novel third-generation high sensitivity troponin I assay.Clin Biochem. 2012 Nov;45(16-17):1295-301. doi: https://doi.org/10.1016/j.clinbiochem.2012.06.005. Epub 2012 Jun 15.

Lyck Hansen M1, Saaby L, Nybo M, Rasmussen LM, Thygesen K, Mickley H et al. Discordant diagnoses of acute myocardial infarction due to the different use of assays and cut-off points of cardiac troponins.Cardiology. 2012;122(4):225-9. doi: https://doi.org/10.1159/000339269. Epub 2012 Aug 10.

Iribarren C, Chandra M, Rana JS, Hlatky MA, Fortmann SP, Quertermous T, et al. High-sensitivity cardiac troponin I and incident coronary heart disease among asymptomatic older adults. Heart. 2016 Aug 1;102(15):1177-82. doi: http://dx.doi.org/10.1136/heartjnl-2015-309136. Epub 2016 Mar 30.

Thorsteinsdottir I, Aspelund T, Gudmundsson E, Eiriksdottir G, Harris TB, Launer LJ, et al. High-Sensitivity Cardiac Troponin I Is a Strong Predictor of Cardiovascular Events and Mortality in the AGES-Reykjavik Community-Based Cohort of Older Individuals. Clin Chem. 2016 Apr;62(4):623-30. doi: https://doi.org/10.1373/clinchem.2015.250811. Epub 2016 Mar 2.

Ferencik M, Liu T, Mayrhofer T, Puchner SB, Lu MT, Maurovich-Horvat P et al. hs-Troponin I Followed by CT Angiography Improves Acute Coronary Syndrome Risk Stratification Accuracy and Work-Up in Acute Chest Pain Patients: Results From ROMICAT II Trial. JACC Cardiovasc Imaging. 2015 Nov;8(11):1272-81. doi: https://doi.org/10.1016/j.jcmg.2015.06.016. Epub 2015 Oct 14.

Aeschbacher S, Schoen T, Bossard M, van der Lely S, Glättli K, Todd J, et al. Relationship between high-sensitivity cardiac troponin I and blood pressure among young and healthy adults. Am J Hypertens. 2015 Jun;28(6):789-96. doi: https://doi.org/10.1093/ajh/hpu226. Epub 2014 Nov 25.

Yiu KH, Lau KK, Zhao CT, Chan YH, Chen Y, Zhen Z et al. Predictive value of high-sensitivity troponin-I for future adverse cardiovascular outcome in stable patients with type 2 diabetes mellitus.Cardiovasc Diabetol. 2014 Mar 25;13:63. doi: https://doi.org/10.1186/1475-2840-13-63.

Bargnoux AS, Kuster N, Patrier L, Dupuy AM, Tachon G, Maurice F, et al. Cardiovascular risk stratification in hemodialysis patients in the era of highly sensitive troponins: should we choose between hs-troponin I and hs-troponin T? Clin Chem Lab Med. 2016 Apr;54(4):673-82. doi: https://doi.org/10.1515/cclm-2015-0071.

Mbagaya W, Luvai A, Lopez B. Biological variation of cardiac troponin in stable haemodialysis patients. Ann Clin Biochem. 2015 Sep;52(Pt 5):562-8. doi: https://doi.org/10.1177%2F0004563215585877. Epub 2015 Apr 23.

McKie PM, Heublein DM, Scott CG, Gantzer ML, Mehta RA, Rodeheffer RJ, et al. Defining high-sensitivity cardiac troponin concentrations in the community. Clin Chem. 2013 Jul;59(7):1099-107. doi: https://doi.org/10.1373/clinchem.2012.198614. Epub 2013 Apr 16.

hsTropI: an early biomarker of acute coronary syndrome & MI
CITATION
DOI: 10.17511/ijmrr.2017.i01.12
Published: 2017-01-31
How to Cite
1.
Sengupta Neogi S, Kumar Kapoor R. hsTropI: an early biomarker of acute coronary syndrome & MI. Int J Med Res Rev [Internet]. 2017Jan.31 [cited 2024Mar.28];5(1):80-7. Available from: https://ijmrr.medresearch.in/index.php/ijmrr/article/view/808
Section
Review Article